Clinical Trials on Treatment-naive Severe Aplastic Anemia in Hong Kong

Total 3 results

The University of Hong Kong

Terminated

Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

Iron Deficiency Anemia Treatment

Hong Kong
Novartis Pharmaceuticals

Completed

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia (SOAR)

Severe Aplastic Anemia

Spain, Italy, Hong Kong, Thailand, Korea, Republic of, Mexico, Turkey, India, Brazil
Novartis Pharmaceuticals

Active, not recruiting

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

Aplastic Anemia

Thailand, Russian Federation, Portugal, United Kingdom, Hong Kong, United States

3

Subscribe